Covenant Asset Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ulta Beauty
ULTA
|
+$1.82M |
| 2 |
Qorvo
QRVO
|
+$1.81M |
| 3 |
KSU
Kansas City Southern
KSU
|
+$1.71M |
| 4 |
Biogen
BIIB
|
+$1.56M |
| 5 |
L3Harris
LHX
|
+$1.39M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Etsy
ETSY
|
+$1.97M |
| 2 |
IQVIA
IQV
|
+$1.82M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
+$1.53M |
| 4 |
Protolabs
PRLB
|
+$1.44M |
| 5 |
Diamondback Energy
FANG
|
+$1.14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.03% |
| 2 | Healthcare | 16.41% |
| 3 | Communication Services | 9.56% |
| 4 | Industrials | 7.85% |
| 5 | Financials | 7.01% |
Similar funds
Covenant Asset Management's Q4 2019 Portfolio in Review
As of Q4 2019, Covenant Asset Management held 154 positions worth $228M, up 15% from $199M the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Covenant Asset Management deployed $10.2M of net new capital in Q4 2019, opening 17 new positions and adding to 40 existing holdings. Its largest new stake was Ulta Beauty: 7,466 shares worth $1.89M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Communication Services.
On the sell side, the largest reduction was Protolabs, an estimated $1.44M trimmed.
- Covenant Asset Management's largest Q4 2019 buy was Ulta Beauty: 7,466 shares worth $1.89M.
- Covenant Asset Management added most to Biogen in Q4 2019, an estimated $1.56M increase.
- Covenant Asset Management's biggest Q4 2019 reduction was Protolabs, cutting an estimated $1.44M.
- Covenant Asset Management fully exited Etsy in Q4 2019, selling an estimated $1.97M.
- Covenant Asset Management's ten largest holdings make up 29% of its $228M portfolio in Q4 2019.
- Covenant Asset Management opened 17 new positions and closed 11 in Q4 2019.
- Covenant Asset Management's portfolio value rose 15% quarter-over-quarter to $228M.
Based on Covenant Asset Management's 13F filing for Q4 2019, filed 24 Jan 2020.